Biological Products, (No Diagnostic Substances)
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 4.38M | $6.0M | 2.34% | +2.41M | 2026-06-30 |
| Perceptive Advisors LLC | 3.14M | $4.0M | 1.68% | -- | 2026-06-30 |
| Marshall Wace, LLP | 1.99M | $3.0M | 1.06% | +1.69M | 2026-06-30 |
| BlackRock, Inc. | 1.67M | $2.0M | 0.89% | +1.19M | 2026-06-30 |
| Jane Street Group, LLC | 1.66M | $2.0M | 0.89% | +1.60M | 2026-06-30 |
| Geode Capital Management, LLC | 1.25M | $1.0M | 0.67% | +642.3K | 2026-06-30 |
| Hrt Financial LP | 784.9K | $1.0M | 0.42% | +717.1K | 2026-06-30 |
| Vanguard Fiduciary Trust Co | 661.7K | $1.0M | 0.35% | +485.1K | 2026-06-30 |
| Gilpin Wealth Management, LLC | 655.0K | $1.0M | 0.35% | -55.2K | 2026-06-30 |
| State Street Corp | 539.8K | -- | 0.29% | +376.7K | 2026-06-30 |
